Darwin Global Management, Ltd. Bridge Bio Pharma, Inc. Transaction History

Darwin Global Management, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $2.89 Million - $13.5 Million	-253,692 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $3.9 Million - $5.34 Million	-83,125 Reduced 24.68%	253,692 $11.9 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $81.5 Million - $112 Million	-1,753,332 Reduced 83.89%	336,817 $20.5 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $79.2 Million - $103 Million	1,427,191 Added 215.28%	2,090,149 $129 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $25.4 Million - $47.1 Million	662,958 New	662,958 $47.1 Million

296

176M

8.64M

2.81M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.78B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Darwin Global Management, Ltd. with notifications on news.